These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1572459)
1. Aspirin usage and its influence on femoro-popliteal vein graft patency. The Femoro-popliteal Bypass Trial Participants. Franks PJ; Sian M; Kenchington GF; Alexander CE; Powell JT Eur J Vasc Surg; 1992 Mar; 6(2):185-8. PubMed ID: 1572459 [TBL] [Abstract][Full Text] [Related]
3. Graft type for femoro-popliteal bypass surgery. Mamode N; Scott RN Cochrane Database Syst Rev; 2000; (2):CD001487. PubMed ID: 10796649 [TBL] [Abstract][Full Text] [Related]
4. Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man. Goldman MD; Simpson D; Hawker RJ; Norcott HC; McCollum CN Ann Surg; 1983 Dec; 198(6):713-6. PubMed ID: 6227296 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387 [TBL] [Abstract][Full Text] [Related]
6. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study. van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237 [TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. Johnson WC; Lee KK J Vasc Surg; 2000 Aug; 32(2):268-77. PubMed ID: 10917986 [TBL] [Abstract][Full Text] [Related]
9. A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts. Satiani B Angiology; 1985 Sep; 36(9):608-16. PubMed ID: 3901826 [TBL] [Abstract][Full Text] [Related]
10. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial. Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164 [TBL] [Abstract][Full Text] [Related]
11. [Clinical and ultrasonographic follow-up after femoro-popliteal venous bypass for lower limb revascularization]. Righini M; Quéré I; Janbon C; Laroche JP J Mal Vasc; 2003 Jun; 28(3):121-9. PubMed ID: 12910188 [TBL] [Abstract][Full Text] [Related]
12. Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass. D'Addato M; Curti T; Bertini D; Donini I; Ferrero R; Fiorani P; Pellegrino F; Vecchioni R; Visconti W; Zinicola N Int Angiol; 1992; 11(2):106-12. PubMed ID: 1402213 [TBL] [Abstract][Full Text] [Related]
13. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency. Hockings BE; Ireland MA; Gotch-Martin KF; Taylor RR Med J Aust; 1993 Sep; 159(6):376-8. PubMed ID: 8377686 [TBL] [Abstract][Full Text] [Related]
14. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y Circulation; 1988 Jun; 77(6):1324-32. PubMed ID: 3286040 [TBL] [Abstract][Full Text] [Related]
16. Influence of a vein cuff on polytetrafluoroethylene grafts for primary femoropopliteal bypass. Raptis S; Miller JH Br J Surg; 1995 Apr; 82(4):487-91. PubMed ID: 7613892 [TBL] [Abstract][Full Text] [Related]
17. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300 [TBL] [Abstract][Full Text] [Related]
18. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study. Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S Circulation; 1994 Mar; 89(3):1138-43. PubMed ID: 8124800 [TBL] [Abstract][Full Text] [Related]
19. The influence of smoking and plasma factors on prosthetic graft patency. Wiseman S; Powell J; Greenhalgh R; McCollum C; Kenchington G; Alexander C; Sian M; Franks P Eur J Vasc Surg; 1990 Feb; 4(1):57-61. PubMed ID: 2182344 [TBL] [Abstract][Full Text] [Related]
20. Venous homografts in infra-inguinal procedures: an eight years experience. De Leersnijder D; Willocx P; Van Marck E; Vanmaele R J Cardiovasc Surg (Torino); 1992; 33(6):633-40. PubMed ID: 1286999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]